Clinical trials
Phase 2 Glioblastoma trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 3 |
| 2024 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Recruiting | 7 |
| Active, not recruiting | 4 |
| Terminated | 2 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AHS Cancer Control Alberta | 3 |
| National Cancer Institute (NCI) | 3 |
| Hoffmann-La Roche | 2 |
| NCIC Clinical Trials Group | 2 |
| Radiation Therapy Oncology Group | 2 |
| Sunnybrook Health Sciences Centre | 2 |
| AbbVie | 1 |
| Apollomics Inc. | 1 |
| Arno Therapeutics | 1 |
| Bassam Abdulkarim | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioblastoma | 32 |
| Brain Neoplasms | 12 |
| Glioma | 9 |
| Gliosarcoma | 9 |
| Astrocytoma | 8 |
| Central Nervous System Neoplasms | 5 |
| Oligodendroglioma | 5 |
| Diffuse Intrinsic Pontine Glioma | 2 |
| Pancreatic Neoplasms | 2 |
| Stomach Neoplasms | 2 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.